Roche exec says COVID-hit health systems at 'more or less' normal capacity

ZURICH (Reuters) - Many patients have overcome initial fears of COVID-19 infections and resumed doctor visits, Roche's drug unit chief said, helping health systems even in hard-hit regions like Texas, Florida and California return to 'more or less' normal capacity. Swiss-based Roche's results this year have been dented as patients around the world shied away from hospitals and clinics during lockdowns, lowering demand for drugs including eye medicine Lucentis, multiple sclerosis drug Ocrevus and hemophilia medicine Hemlibra and leading to a 10% second-quarter sales decline. Bill Anderson, CEO of Roche's main pharmaceuticals unit with about $50 billion in annual sales, said in an interview on Tuesday that most of the world's health care systems have re-stabilized, 'even in places that had reasonably high levels of COVID'.

Reuters September 16, 2020 00:07:09 IST
Roche exec says COVID-hit health systems at 'more or less' normal capacity

Roche exec says COVIDhit health systems at more or less normal capacity

ZURICH (Reuters) - Many patients have overcome initial fears of COVID-19 infections and resumed doctor visits, Roche's drug unit chief said, helping health systems even in hard-hit regions like Texas, Florida and California return to "more or less" normal capacity.

Swiss-based Roche's results this year have been dented as patients around the world shied away from hospitals and clinics during lockdowns, lowering demand for drugs including eye medicine Lucentis, multiple sclerosis drug Ocrevus and hemophilia medicine Hemlibra and leading to a 10% second-quarter sales decline.

Bill Anderson, CEO of Roche's main pharmaceuticals unit with about $50 billion in annual sales, said in an interview on Tuesday that most of the world's health care systems have re-stabilized, "even in places that had reasonably high levels of COVID".

"In the month of August, you had places like Texas, Florida, California with a lot of infections," Anderson told Reuters.

"But we saw the health care system was more or less back at normal capacity. I think that was probably mostly a one-time thing, where people were really unsure, they were afraid to go out of the house, afraid to go to their family doctor, because maybe they would get COVID."

The public's understanding of risks has grown since the pandemic began, he added, boosting their confidence to move more freely.

Anderson's description of recovering demand underpins Roche move this summer to stick to its original 2020 forecast -- for full-year sales to grow in the low- to mid-single-digit percentage range -- despite the second-quarter revenue tumble.

Anderson did not give specific sales figures. Roche, which is expecting initial clinical trial data on the anti-COVID-19 drug it is developing with U.S.-based Regeneron this month, reports third-quarter sales on Oct. 15.

(Reporting by John Miller; Editing by Michael Shields)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.